Thomas L. Riley

7.1k total citations
27 papers, 1.5k citations indexed

About

Thomas L. Riley is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Reproductive Medicine. According to data from OpenAlex, Thomas L. Riley has authored 27 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 8 papers in Reproductive Medicine. Recurrent topics in Thomas L. Riley's work include Ovarian cancer diagnosis and treatment (8 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Lung Cancer Treatments and Mutations (8 papers). Thomas L. Riley is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Lung Cancer Treatments and Mutations (8 papers). Thomas L. Riley collaborates with scholars based in United States, Canada and France. Thomas L. Riley's co-authors include Christine D. Berg, Martin C. Tammemägi, Philip C. Prorok, Lawrence R. Ragard, Timothy R. Church, William G. Hocking, Paul A. Kvale, John Commins, Saundra S. Buys and Paul F. Pinsky and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Thomas L. Riley

26 papers receiving 1.5k citations

Peers

Countries citing papers authored by Thomas L. Riley

Since Specialization

Citations

This map shows the geographic impact of Thomas L. Riley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas L. Riley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas L. Riley more than expected).

Fields of papers citing papers by Thomas L. Riley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas L. Riley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas L. Riley. The network helps show where Thomas L. Riley may publish in the future.

Co-authorship network of co-authors of Thomas L. Riley

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas L. Riley. A scholar is included among the top collaborators of Thomas L. Riley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas L. Riley. Thomas L. Riley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and Validation of a Risk Prediction Model for Second Primary Lung Cancer 2021 ·JNCI Journal of the National Cancer Institute ·Eunji Choi, Nilotpal Sanyal, Victoria Y. Ding, Rebecca M. Gardner, Jacqueline V. Aredo, Justin Lee, Julie Wu, Thomas Hickey, Brian Barrett, Thomas L. Riley, Lynne R. Wilkens, Ann N. Leung, Loı̈c Le Marchand, Martin C. Tammemägi, Rayjean J. Hung, Christopher I. Amos, Neal D. Freedman, Iona Cheng, Heather A. Wakelee, Summer S. Han	13
2	Factors Associated With Small Aggressive Non–Small Cell Lung Cancers in the National Lung Screening Trial: A Validation Study 2018 ·JNCI Cancer Spectrum ·Matthew T. Warkentin, Martin C. Tammemägi, Matthew T. Freedman, Lawrence R. Ragard, William G. Hocking, Paul A. Kvale, Darren R. Brenner, Ping Hu, Thomas L. Riley, John Commins, Timothy R. Church, Christine D. Berg	3
3	Incidence and Mortality of Colorectal Cancer in Individuals With a Family History of Colorectal Cancer 2015 ·Gastroenterology ·Robert E. Schoen, Anthony Razzak, Kelly J. Yu, Sonja I. Berndt, (unknown), Thomas L. Riley, Paul F. Pinsky	64
4	Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts 2014 ·PLoS Medicine ·Martin C. Tammemägi, Timothy R. Church, William G. Hocking, Gerard A. Silvestri, Paul A. Kvale, Thomas L. Riley, John Commins, Christine D. Berg	202
5	Impact of Lung Cancer Screening Results on Smoking Cessation 2014 ·JNCI Journal of the National Cancer Institute ·Martin C. Tammemägi, Christine D. Berg, Thomas L. Riley, (unknown), Kathryn L. Taylor	161
6	Modified Gleason Grade of Prostatic Adenocarcinomas Detected in the PLCO Cancer Screening Trial 2014 ·The Journal of Urology ·Peter A. Humphrey, Thomas Hickey, Thomas L. Riley, Jerome Mabie, (unknown), Marshall Strother, Gerald L. Andriole	1
7	Assessing the Risk of Ovarian Malignancy in Asymptomatic Women With Abnormal CA 125 and Transvaginal Ultrasound Scans in the Prostate, Lung, Colorectal, and Ovarian Screening Trial 2013 ·Obstetrics and Gynecology ·Edward E. Partridge, Robert T. Greenlee, Thomas L. Riley, John Commins, Lawrence R. Ragard, (unknown), Saundra S. Buys, Philip C. Prorok, Mona N. Fouad	21
8	Non‐steroidal anti‐inflammatory drug use and the risk of benign prostatic hyperplasia‐related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial 2012 ·British Journal of Urology ·Siobhan Sutcliffe, Robert L. Grubb, Elizabeth A. Platz, Lawrence R. Ragard, Thomas L. Riley, (unknown), Richard B. Hayes, Ann W. Hsing, Gerald L. Andriole, (unknown)	29
9	588 Effect of Flexible Sigmoidoscopy Screening on Incidence and Mortality From Colorectal Cancer in the PLCO Screening Trial 2012 ·Gastroenterology ·Robert E. Schoen, Paul F. Pinsky, Joel L. Weissfeld, Lance Yokochi, Timothy R. Church, Adeyinka O. Laiyemo, Robert S. Bresalier, Thomas L. Riley, Philip C. Prorok, Christine D. Berg	1
10	Longitudinal evaluation of CA-125 velocity and prediction of ovarian cancer 2011 ·Gynecologic Oncology ·(unknown), John Commins, Edward E. Partridge, Thomas L. Riley, Philip C. Prorok, Christine Cole Johnson, Saundra S. Buys	14
11	Lung Cancer Risk Prediction: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Models and Validation 2011 ·JNCI Journal of the National Cancer Institute ·Martin C. Tammemägi, Paul F. Pinsky, Neil E. Caporaso, Paul A. Kvale, William G. Hocking, Timothy R. Church, Thomas L. Riley, John Commins, Martin M. Oken, Christine D. Berg, Philip C. Prorok	209
12	Prevalence, Incidence, and Natural History of Simple Ovarian Cysts Among Women >55 Years Old in a Large Cancer Screening Trial 2010 ·Obstetrical & Gynecological Survey ·Robert T. Greenlee, Bruce Kessel, Craig Williams, Thomas L. Riley, Lawrence R. Ragard, Patricia Hartge, Saundra S. Buys, Edward E. Partridge, Douglas J. Reding	1
13	Lung Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial 2010 ·JNCI Journal of the National Cancer Institute ·William G. Hocking, Ping Hu, Martin M. Oken, (unknown), Paul A. Kvale, Philip C. Prorok, Lawrence R. Ragard, John Commins, David A. Lynch, Gerald L. Andriole, Saundra S. Buys, Mona N. Fouad, Carl R. Fuhrman, Claudine Isaacs, Lance Yokochi, Thomas L. Riley, Paul F. Pinsky, John K. Gohagan, Christine D. Berg	71
14	Prevalence, incidence, and natural history of simple ovarian cysts among women >55 years old in a large cancer screening trial 2010 ·American Journal of Obstetrics and Gynecology ·Robert T. Greenlee, Bruce Kessel, Craig Williams, Thomas L. Riley, Lawrence R. Ragard, Patricia Hartge, Saundra S. Buys, Edward E. Partridge, Douglas J. Reding	85
15	Prediction of True Positive Lung Cancers in Individuals with Abnormal Suspicious Chest Radiographs—A Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Study 2009 ·Journal of Thoracic Oncology ·Martin C. Tammemägi, Matthew T. Freedman, Paul F. Pinsky, Martin M. Oken, Ping Hu, Thomas L. Riley, Lawrence R. Ragard, Christine D. Berg, Philip C. Prorok	25
16	The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial 2008 ·Gynecologic Oncology ·Christine Cole Johnson, Bruce Kessel, Thomas L. Riley, Lawrence R. Ragard, Craig Williams, (unknown), Saundra S. Buys	84
17	Factors Associated with Human Small Aggressive Non–Small Cell Lung Cancer 2007 ·Cancer Epidemiology Biomarkers & Prevention ·Martin C. Tammemägi, Matthew T. Freedman, Timothy R. Church, Martin M. Oken, William G. Hocking, Paul A. Kvale, Ping Hu, Thomas L. Riley, Lawrence R. Ragard, Philip C. Prorok, Christine D. Berg	8
18	Ovarian Cancer Screening in Women With a Family History of Breast or Ovarian Cancer 2006 ·Obstetrics and Gynecology ·James V. Lacey, Mark H. Greene, Saundra S. Buys, Douglas Reding, Thomas L. Riley, Christine D. Berg, Richard M. Fagerstrom, Patricia Hartge	22
19	Baseline Chest Radiograph for Lung Cancer Detection in the Randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial 2005 ·JNCI Journal of the National Cancer Institute ·Martin M. Oken, Pamela M. Marcus, Ping Hu, Thomas Beck, William G. Hocking, Paul A. Kvale, (unknown), Thomas L. Riley, (unknown), (unknown), David L. Levin, Philip C. Prorok, John K. Gohagan	95
20	Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trial 2005 ·American Journal of Obstetrics and Gynecology ·Saundra S. Buys, Edward E. Partridge, Mark H. Greene, Philip C. Prorok, Douglas J. Reding, Thomas L. Riley, Patricia Hartge, Richard M. Fagerstrom, Lawrence R. Ragard, David Chia, Grant Izmirlian, Mona N. Fouad, Christine Cole Johnson, John K. Gohagan	236

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact